154 related articles for article (PubMed ID: 28376405)
1. DNA methyltransferase 1 mediated aberrant methylation and silencing of SHP-1 gene in chronic myelogenous leukemia cells.
Li Y; Liu X; Guo X; Liu X; Luo J
Leuk Res; 2017 Jul; 58():9-13. PubMed ID: 28376405
[TBL] [Abstract][Full Text] [Related]
2. [Relationship between DNMT1 and Methylation of SHP-1 Promoter 2 in K562 Cells].
Liu XD; Liu X; Guo XF; Luo JM; Li YH
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2018 Apr; 26(2):401-406. PubMed ID: 29665905
[TBL] [Abstract][Full Text] [Related]
3. [SHP-1 gene in the disease progression of chronic myeloid leukemia].
Li Y; Wang X; Yang L; Pan Y; Shang Y; Luo J
Zhonghua Xue Ye Xue Za Zhi; 2014 Dec; 35(12):1074-8. PubMed ID: 25543700
[TBL] [Abstract][Full Text] [Related]
4. Methylation and decreased expression of SHP-1 are related to disease progression in chronic myelogenous leukemia.
Li Y; Yang L; Pan Y; Yang J; Shang Y; Luo J
Oncol Rep; 2014 May; 31(5):2438-46. PubMed ID: 24647617
[TBL] [Abstract][Full Text] [Related]
5. Research on the epigenetic regulation mechanism of the PTPN6 gene in advanced chronic myeloid leukaemia.
Zhang X; Yang L; Liu X; Nie Z; Wang X; Pan Y; Luo J
Br J Haematol; 2017 Sep; 178(5):728-738. PubMed ID: 28480959
[TBL] [Abstract][Full Text] [Related]
6. [Down-regulation of transcription factor PU.1 via abnormal epigenetic modification in chronic myeloid leukemia].
Yang H; Yan JS; Tao R; Hao SG; Liang H; Ma LY
Zhonghua Zhong Liu Za Zhi; 2012 Mar; 34(3):169-75. PubMed ID: 22780968
[TBL] [Abstract][Full Text] [Related]
7. STAT3- and DNA methyltransferase 1-mediated epigenetic silencing of SHP-1 tyrosine phosphatase tumor suppressor gene in malignant T lymphocytes.
Zhang Q; Wang HY; Marzec M; Raghunath PN; Nagasawa T; Wasik MA
Proc Natl Acad Sci U S A; 2005 May; 102(19):6948-53. PubMed ID: 15870198
[TBL] [Abstract][Full Text] [Related]
8. [Overexpression of Shp-2 is associated with the unlimited growth and apoptosis resistance of p210 bcr-abl-mediated chronic myeloid leukemia].
Zhu XZ; Yu YZ; Fang YM; Liang Y; Lü QH; Xu RZ
Zhonghua Yi Xue Za Zhi; 2005 Jul; 85(27):1903-6. PubMed ID: 16255985
[TBL] [Abstract][Full Text] [Related]
9. Expression, prognostic significance and mutational analysis of protein tyrosine phosphatase SHP-1 in chronic myeloid leukemia.
Papadopoulou V; Kontandreopoulou E; Panayiotidis P; Roumelioti M; Angelopoulou M; Kyriazopoulou L; Diamantopoulos PT; Vaiopoulos G; Variami E; Kotsianidis I; Athina Viniou N
Leuk Lymphoma; 2016 May; 57(5):1182-8. PubMed ID: 26373709
[TBL] [Abstract][Full Text] [Related]
10. [Effect of a methylation inhibitor 5-aza-2'-deoxycytidine on SHP-1 gene expression, proliferation and apoptosis in K562 cells].
Luo JM; Li Y; Yang L; Liu XJ; Wen SP; Wang FX; Zhang JY; Zhang XJ; Dong ZR
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2009 Apr; 17(2):309-14. PubMed ID: 19379557
[TBL] [Abstract][Full Text] [Related]
11. Arsenic trioxide inhibits DNA methyltransferase and restores TMS1 gene expression in K562 cells.
Li H; Wang Y; Xu W; Dong L; Guo Y; Bi K; Zhu C
Acta Haematol; 2015; 133(1):18-25. PubMed ID: 24993472
[TBL] [Abstract][Full Text] [Related]
12. Effects of DNMT1 silencing on malignant phenotype and methylated gene expression in cervical cancer cells.
Zhang Y; Chen FQ; Sun YH; Zhou SY; Li TY; Chen R
J Exp Clin Cancer Res; 2011 Oct; 30(1):98. PubMed ID: 21999220
[TBL] [Abstract][Full Text] [Related]
13. GPX3 promoter is methylated in chronic myeloid leukemia.
Yao DM; Zhou JD; Zhang YY; Yang L; Wen XM; Yang J; Guo H; Chen Q; Lin J; Qian J
Int J Clin Exp Pathol; 2015; 8(6):6450-7. PubMed ID: 26261521
[TBL] [Abstract][Full Text] [Related]
14. Enhancing SHP-1 expression with 5-azacytidine may inhibit STAT3 activation and confer sensitivity in lestaurtinib (CEP-701)-resistant FLT3-ITD positive acute myeloid leukemia.
Al-Jamal HA; Mat Jusoh SA; Hassan R; Johan MF
BMC Cancer; 2015 Nov; 15():869. PubMed ID: 26547689
[TBL] [Abstract][Full Text] [Related]
15. [Silencing DNMT1 Attenuates the Effect of WIF-1 Gene Promoter Methylation on the Biological Behavior of Chronic Myeloid Leukemia K562 Cells].
Wu K; Jin Z; Li YX; Li X; Cheng SJ; Li YH; Guo C
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2021 Dec; 29(6):1768-1774. PubMed ID: 34893108
[TBL] [Abstract][Full Text] [Related]
16. Expression of DNA methyltransferases DNMT1, 3A, and 3B in normal hematopoiesis and in acute and chronic myelogenous leukemia.
Mizuno S; Chijiwa T; Okamura T; Akashi K; Fukumaki Y; Niho Y; Sasaki H
Blood; 2001 Mar; 97(5):1172-9. PubMed ID: 11222358
[TBL] [Abstract][Full Text] [Related]
17. Hypomethylation-mediated H19 overexpression increases the risk of disease evolution through the association with BCR-ABL transcript in chronic myeloid leukemia.
Zhou JD; Lin J; Zhang TJ; Ma JC; Li XX; Wen XM; Guo H; Xu ZJ; Deng ZQ; Zhang W; Qian J
J Cell Physiol; 2018 Mar; 233(3):2444-2450. PubMed ID: 28776669
[TBL] [Abstract][Full Text] [Related]
18. Down-regulation of hematopoiesis master regulator PU.1 via aberrant methylation in chronic myeloid leukemia.
Yang H; Liang H; Yan JS; Tao R; Hao SG; Ma LY
Int J Hematol; 2012 Jul; 96(1):65-73. PubMed ID: 22674382
[TBL] [Abstract][Full Text] [Related]
19. ABL1 promoter methylation can exist independently of BCR-ABL transcription in chronic myeloid leukemia hematopoietic progenitors.
Sun B; Jiang G; Zaydan MA; La Russa VF; Safah H; Ehrlich M
Cancer Res; 2001 Sep; 61(18):6931-7. PubMed ID: 11559572
[TBL] [Abstract][Full Text] [Related]
20. Gene silencing of the tyrosine phosphatase SHP1 gene by aberrant methylation in leukemias/lymphomas.
Oka T; Ouchida M; Koyama M; Ogama Y; Takada S; Nakatani Y; Tanaka T; Yoshino T; Hayashi K; Ohara N; Kondo E; Takahashi K; Tsuchiyama J; Tanimoto M; Shimizu K; Akagi T
Cancer Res; 2002 Nov; 62(22):6390-4. PubMed ID: 12438221
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]